Show simple item record

Efficacy/safety Of Ocrelizumab In Relapsing-remitting MS Patients With Suboptimal Response To Prior Disease-modifying Therapies (1-yr Interim Results)

dc.contributor.authorWiendl, H.
dc.contributor.authorComi, G.
dc.contributor.authorVan Wijmeersch, B.
dc.contributor.authorBuffels, R.
dc.contributor.authorWei, W.
dc.contributor.authorVermersch, P.
dc.contributor.authorEralinna, J.
dc.contributor.authorNicholas, R.
dc.contributor.authorOreja-Guevara, C.
dc.contributor.authorSiva, A.
dc.date.accessioned2021-03-02T18:36:05Z
dc.date.available2021-03-02T18:36:05Z
dc.identifier.citationVermersch P., Eralinna J., Nicholas R., Oreja-Guevara C., Siva A., Van Wijmeersch B., Wiendl H., Buffels R., Wei W., Comi G., "Efficacy/safety Of Ocrelizumab In Relapsing-remitting MS Patients With Suboptimal Response To Prior Disease-modifying Therapies (1-yr Interim Results)", Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) Forum, Florida, Amerika Birleşik Devletleri, 27 - 29 Şubat 2020, cilt.26, ss.32
dc.identifier.othervv_1032021
dc.identifier.otherav_38c2e3ff-2677-40db-b769-ef0dcedde633
dc.identifier.urihttp://hdl.handle.net/20.500.12627/5293
dc.language.isoeng
dc.subjectSinirbilim ve Davranış
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectNöroloji
dc.subjectYaşam Bilimleri
dc.subjectKlinik Tıp (MED)
dc.subjectTemel Bilimler
dc.subjectNEUROSCIENCES
dc.subjectKlinik Tıp
dc.subjectKLİNİK NEUROLOJİ
dc.titleEfficacy/safety Of Ocrelizumab In Relapsing-remitting MS Patients With Suboptimal Response To Prior Disease-modifying Therapies (1-yr Interim Results)
dc.typeBildiri
dc.contributor.departmentFondation I-SITE ULNE , ,
dc.identifier.volume26
dc.contributor.firstauthorID2281281


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record